Insider trading

Period: 120 months Stock: AVTX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

310 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

310 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

310 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

310 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
310 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
310 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

310 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
16 Sep 2026
Sullivan Christopher Ryan Chief Financial Officer
Sold on a plan
$202.44K 12,394 at 16.33
23.7%
Planned (10b5-1)
10 Sep 2026
Sullivan Christopher Ryan Chief Financial Officer
Sold on a plan
$179.46K 10,185 at 17.62
20.3%
Planned (10b5-1)
28 Aug 2026
Doyle Mittie Chief Medical Officer
Sold on a plan
$13.58K 679 at 20.00
1.3%
Planned (10b5-1)
18 Aug 2026
Sullivan Christopher Ryan Chief Financial Officer
Sold on a plan
$622.32K 31,031 at 20.05
43.7%
Planned (10b5-1)
17 Aug 2026
Sullivan Christopher Ryan Chief Financial Officer
Sold on a plan 2×
$828.10K 41,694 at 19.86
51.1%
Sold half or more
17 Aug 2026
Doyle Mittie Chief Medical Officer
Sold on a plan
$20.00K 1,000 at 20.00
1.9%
Planned (10b5-1)
11 Aug 2026
Riley Jennifer Chief Strategy Officer
Sold at will
$52.01K 2,655 at 19.59
6.7%
Not planned
10 Aug 2026
Doyle Mittie Chief Medical Officer
Sold on a plan
$13.58K 679 at 20.00
1.3%
Planned (10b5-1)
27 Jul 2026
Doyle Mittie Chief Medical Officer
Sold on a plan
$20.00K 1,000 at 20.00
1.9%
Planned (10b5-1)
30 Jun 2026
Doyle Mittie Chief Medical Officer
Sold on a plan
$93.08K 4,654 at 20.00
8.2%
Planned (10b5-1)
23 Jun 2026
Doyle Mittie Chief Medical Officer
Sold on a plan
$26.10K 1,450 at 18.00
2.7%
Planned (10b5-1)
28 May 2026
Doyle Mittie Chief Medical Officer
Sold on a plan
$10.86K 679 at 16.00
1.4%
Planned (10b5-1)
15 May 2026
Doyle Mittie Chief Medical Officer
Sold on a plan
$56.28K 3,000 at 18.76
45.3%
Planned (10b5-1)
7 May 2026
Sullivan Christopher Ryan Chief Financial Officer
Sold on a plan
$448.82K 18,606 at 24.12
97.8%
Sold half or more
6 May 2026
Doyle Mittie Chief Medical Officer
Sold on a plan 5×
$2.20M 106,555 at 20.68
96.7%
Sold half or more
6 May 2026
VARKI PAUL Chief Legal Officer
Sold on a plan 5×
$1.51M 75,063 at 20.17
95.4%
Sold half or more
6 May 2026
Sullivan Christopher Ryan Chief Financial Officer
Sold on a plan 5×
$948.72K 47,000 at 20.19
99.1%
Sold half or more
6 May 2026
Chan Mitchell Director
Sold on a plan
$72.46K 3,167 at 22.88
50.0%
Sold half or more
5 May 2026
Doyle Mittie Chief Medical Officer
Sold on a plan
$26.86K 1,679 at 16.00
31.7%
Planned (10b5-1)
30 Apr 2026
Sullivan Christopher Ryan Chief Financial Officer
Sold on a plan
$111.85K 8,457 at 13.23
95.2%
Sold half or more
29 Apr 2026
Sullivan Christopher Ryan Chief Financial Officer
Sold on a plan
$110.74K 8,458 at 13.09
48.8%
Planned (10b5-1)
6 Apr 2026
Doyle Mittie Chief Medical Officer
Sold on a plan
$71.51K 3,970 at 18.01
52.3%
Sold half or more
2 Apr 2026
Sullivan Christopher Ryan Chief Financial Officer
Sold on a plan 2×
$136.82K 7,980 at 17.15
31.5%
Planned (10b5-1)
1 Apr 2026
Sullivan Christopher Ryan Chief Financial Officer
Sold on a plan 2×
$133.77K 7,979 at 16.77
24.0%
Planned (10b5-1)
1 Apr 2026
Doyle Mittie Chief Medical Officer
Sold on a plan
$10.86K 679 at 16.00
15.8%
Planned (10b5-1)
16 Mar 2026
Doyle Mittie Chief Medical Officer
Sold on a plan
$411.61K 25,492 at 16.15
87.6%
Sold half or more
14 Nov 2025
Goldman Jonathan Director
Sold at will 2×
$162.94K 11,367 at 14.33
100%
Sold half or more
13 Nov 2024
Almenoff June Sherie Director · indirect
Bought
$6.50K 500 at 13.00
100%
Largest buy in 3 yrs
12 Nov 2024
Almenoff June Sherie Director · indirect
Bought
$6.25K 500 at 12.50
opened
First buy on file
27 Jun 2023
ARMISTICE CAPITAL, LLC 10% owner · indirect
Sold at will
$486.89K 937,404 at 0.52
56.2%
Sold half or more
26 Jun 2023
ARMISTICE CAPITAL, LLC 10% owner · indirect
Sold at will
$1.68M 2,746,138 at 0.61
62.2%
Sold half or more
26 Jun 2023
Caissa Capital Management ltd. 10% owner · indirect
Sold at will
$917.15K 1,425,700 at 0.64
100%
Sold half or more
26 Jun 2023
Sold at will
$113.03K 182,300 at 0.62
100%
Sold half or more
20 Jun 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought
$8.29K 2,000 at 4.14
0.1%
16 Jun 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought
$11.71K 3,000 at 3.90
0.2%
15 Jun 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought
$11.64K 3,160 at 3.68
0.2%
14 Jun 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought
$20.87K 6,000 at 3.48
0.4%
13 Jun 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought
$33.44K 8,750 at 3.82
0.6%
12 Jun 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought
$9.32K 2,149 at 4.34
0.2%
9 Jun 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought
$20.90K 5,044 at 4.14
0.4%
9 Jun 2023
NEIL GARRY ARTHUR CEO and Chairman of the Board
Bought
$13.68K 4,000 at 3.42
43.4%
Largest buy in 3 yrs
9 Jun 2023
Sullivan Christopher Ryan Chief Financial Officer
Bought
$1.75K 511 at 3.42
68.0%
+68% of stake
8 Jun 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought
$25.13K 6,398 at 3.93
0.5%
7 Jun 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought
$10.42K 2,984 at 3.49
0.2%
31 May 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought
$2.42K 844 at 2.87
0.1%
30 May 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought
$1.92K 671 at 2.87
0.0%
25 May 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought
$5.54K 2,000 at 2.77
0.1%
24 May 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought 2×
$26.82K 9,000 at 2.98
0.7%
22 May 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought
$23.36K 7,000 at 3.34
0.5%
19 May 2023
Caissa Capital Management ltd. 10% owner · indirect
Bought
$22.85K 6,500 at 3.52
0.5%
Showing 1–50 of 310. Page 1 of 7 Older →